433 related articles for article (PubMed ID: 9264271)
21. [Study of relationship between arsenic methylation and skin lesion in a population with long-term high arsenic exposure].
Su L; Cheng Y; Lin S; Wu C
Wei Sheng Yan Jiu; 2007 May; 36(3):336-40. PubMed ID: 17712955
[TBL] [Abstract][Full Text] [Related]
22. Arsenic methylation capacity and its correlation with skin lesions induced by contaminated drinking water consumption in residents of chronic arsenicosis area.
Li X; Li B; Xu Y; Wang Y; Jin Y; Itoh T; Yoshida T; Sun G
Environ Toxicol; 2011 Apr; 26(2):118-23. PubMed ID: 19768748
[TBL] [Abstract][Full Text] [Related]
23. DMPS-arsenic challenge test. I: Increased urinary excretion of monomethylarsonic acid in humans given dimercaptopropane sulfonate.
Aposhian HV; Arroyo A; Cebrian ME; del Razo LM; Hurlbut KM; Dart RC; Gonzalez-Ramirez D; Kreppel H; Speisky H; Smith A; Gonsebatt ME; Ostrosky-Wegman P; Aposhian MM
J Pharmacol Exp Ther; 1997 Jul; 282(1):192-200. PubMed ID: 9223554
[TBL] [Abstract][Full Text] [Related]
24. Arsenic concentrations in prediagnostic toenails and the risk of bladder cancer in a cohort study of male smokers.
Michaud DS; Wright ME; Cantor KP; Taylor PR; Virtamo J; Albanes D
Am J Epidemiol; 2004 Nov; 160(9):853-9. PubMed ID: 15496537
[TBL] [Abstract][Full Text] [Related]
25. Arsenic methylation, urinary arsenic metabolites and human diseases: current perspective.
Tseng CH
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2007; 25(1):1-22. PubMed ID: 17365340
[TBL] [Abstract][Full Text] [Related]
26. Speciation of arsenic in biological samples.
Mandal BK; Ogra Y; Anzai K; Suzuki KT
Toxicol Appl Pharmacol; 2004 Aug; 198(3):307-18. PubMed ID: 15276410
[TBL] [Abstract][Full Text] [Related]
27. Ingested arsenic, characteristics of well water consumption and risk of different histological types of lung cancer in northeastern Taiwan.
Chen CL; Chiou HY; Hsu LI; Hsueh YM; Wu MM; Chen CJ
Environ Res; 2010 Jul; 110(5):455-62. PubMed ID: 19735913
[TBL] [Abstract][Full Text] [Related]
28. Risk assessment of arsenic-induced internal cancer at long-term low dose exposure.
Liao CM; Shen HH; Chen CL; Hsu LI; Lin TL; Chen SC; Chen CJ
J Hazard Mater; 2009 Jun; 165(1-3):652-63. PubMed ID: 19062162
[TBL] [Abstract][Full Text] [Related]
29. Arsenic methylation and bladder cancer risk in Taiwan.
Chen YC; Su HJ; Guo YL; Hsueh YM; Smith TJ; Ryan LM; Lee MS; Christiani DC
Cancer Causes Control; 2003 May; 14(4):303-10. PubMed ID: 12846360
[TBL] [Abstract][Full Text] [Related]
30. Association of arsenic-contaminated drinking-water with prevalence of skin cancer in Wisconsin's Fox River Valley.
Knobeloch LM; Zierold KM; Anderson HA
J Health Popul Nutr; 2006 Jun; 24(2):206-13. PubMed ID: 17195561
[TBL] [Abstract][Full Text] [Related]
31. Gene polymorphisms of glutathione S-transferase omega 1 and 2, urinary arsenic methylation profile and urothelial carcinoma.
Chung CJ; Pu YS; Su CT; Huang CY; Hsueh YM
Sci Total Environ; 2011 Jan; 409(3):465-70. PubMed ID: 21094982
[TBL] [Abstract][Full Text] [Related]
32. The risk of arsenic induced skin lesions in Bangladeshi men and women is affected by arsenic metabolism and the age at first exposure.
Lindberg AL; Rahman M; Persson LA; Vahter M
Toxicol Appl Pharmacol; 2008 Jul; 230(1):9-16. PubMed ID: 18336856
[TBL] [Abstract][Full Text] [Related]
33. Changes in urinary arsenic methylation profiles in a 15-year interval after cessation of arsenic ingestion in southwest Taiwan.
Huang YK; Huang YL; Hsueh YM; Wang JT; Yang MH; Chen CJ
Environ Health Perspect; 2009 Dec; 117(12):1860-6. PubMed ID: 20049204
[TBL] [Abstract][Full Text] [Related]
34. A Weibull-PBPK model for assessing risk of arsenic-induced skin lesions in children.
Liao CM; Lin TL; Chen SC
Sci Total Environ; 2008 Mar; 392(2-3):203-17. PubMed ID: 18207220
[TBL] [Abstract][Full Text] [Related]
35. Arsenic speciation in urine from acute promyelocytic leukemia patients undergoing arsenic trioxide treatment.
Wang Z; Zhou J; Lu X; Gong Z; Le XC
Chem Res Toxicol; 2004 Jan; 17(1):95-103. PubMed ID: 14727923
[TBL] [Abstract][Full Text] [Related]
36. Physiologically based pharmacokinetic modeling of arsenic in the mouse.
Gentry PR; Covington TR; Mann S; Shipp AM; Yager JW; Clewell HJ
J Toxicol Environ Health A; 2004 Jan; 67(1):43-71. PubMed ID: 14668111
[TBL] [Abstract][Full Text] [Related]
37. Inorganic arsenic exposure and type 2 diabetes mellitus in Mexico.
Coronado-González JA; Del Razo LM; García-Vargas G; Sanmiguel-Salazar F; Escobedo-de la Peña J
Environ Res; 2007 Jul; 104(3):383-9. PubMed ID: 17475235
[TBL] [Abstract][Full Text] [Related]
38. Arsenic methylation, GSTT1, GSTM1, GSTP1 polymorphisms, and skin lesions.
McCarty KM; Chen YC; Quamruzzaman Q; Rahman M; Mahiuddin G; Hsueh YM; Su L; Smith T; Ryan L; Christiani DC
Environ Health Perspect; 2007 Mar; 115(3):341-5. PubMed ID: 17431481
[TBL] [Abstract][Full Text] [Related]
39. Lung cancer and exposure to arsenic in rural Bangladesh.
Mostafa MG; McDonald JC; Cherry NM
Occup Environ Med; 2008 Nov; 65(11):765-8. PubMed ID: 18417558
[TBL] [Abstract][Full Text] [Related]
40. Urinary arsenic profiles and the risks of cancer mortality: a population-based 20-year follow-up study in arseniasis-endemic areas in Taiwan.
Chung CJ; Huang YL; Huang YK; Wu MM; Chen SY; Hsueh YM; Chen CJ
Environ Res; 2013 Apr; 122():25-30. PubMed ID: 23276485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
